SYRRX
Syrrx Inc focuses on drug targets that have been validated in human clinical trials and directs its efforts toward therapeutics to treat metabolic diseases, cancer, and inflammation. Syrrx exploits its competitive advantage in high-throughput structural biology to be the first organization to determine the three dimensional structure of known drug targets. Syrrx then uses these structures to drive iterative, structure-based drug design programs to efficiently generate potential drug candidates. ... Syrrx has an ongoing partnership for the development and commercialization of Syrrx-designed human dipeptidyl peptidase IV (DPP IV) inhibitors as drug products for the treatment of type 2 diabetes and other major human diseases. Syrrx also has a strategic alliance for the discovery and early development of inhibitors targeting human HDACs and HSD1.
SYRRX
Industry:
Biotechnology Clinical Trials Commercial Content Discovery
Founded:
1999-02-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.syrrx.com
Total Employee:
1+
Status:
Active
Contact:
(858)622-8528
Total Funding:
23.6 M USD
Technology used in webpage:
Domain Not Resolving Network Solutions Ads WidgetBox
Similar Organizations
BIND Therapeutics
BIND Therapeutics is a clinical-stage nanomedicine platform company developing Accurins, a class of highly selective, targeted therapeutics.
Parnell Living Science
Parnell is a fully integrated pharmaceutical company dedicated to finding animal health solutions that matter.
Recensa Therapeutics
Recensa Therapeutics, Inc. has a new approach to treating psoriasis: targeting oxidative stress.
Current Advisors List
Current Employees Featured
Founder
Investors List
HBM Partners
HBM Partners investment in Venture Round - Syrrx
CMEA Capital
CMEA Capital investment in Series A - Syrrx
Versant Ventures
Versant Ventures investment in Series A - Syrrx
MPM Capital
MPM Capital investment in Series A - Syrrx
Bay City Capital
Bay City Capital investment in Series A - Syrrx
Official Site Inspections
http://www.syrrx.com
- Host name: 192.64.119.71
- IP address: 192.64.119.71
- Location: Los Angeles United States
- Latitude: 34.0318
- Longitude: -118.4252
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90064
More informations about "Syrrx"
Syrrx - Crunchbase Company Profile & Funding
Syrrx exploits its competitive advantage in high-throughput structural biology to be the first organization to determine the three dimensional structure of known …See details»
Syrrx - 2025 Company Profile, Funding & Competitors - Tracxn
Syrrx then uses these structures to drive iterative, structure-based drug design programs to efficiently generate potential drug candidates. Syrrx has an ongoing partnership for the …See details»
Syrrx 2025 Company Profile: Valuation, Investors, Acquisition
Syrrx was founded in 1999. Where is Syrrx headquartered? Syrrx is headquartered in San Diego, CA. What industry is Syrrx in? Syrrx’s primary industry is Biotechnology. Is Syrrx a private or …See details»
Syrrx - Products, Competitors, Financials, Employees, Headquarters ...
That company was Syrrx, a private San Diego-based biotech that used X-ray crystallography to help determine the structures of disease-related molecules so drugs could be designed to …See details»
Syrrx - Funding, Financials, Valuation & Investors - Crunchbase
Syrrx, Inc. is a drug discovery company committed to redefining the way medicines are discovered. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. ... How much …See details»
Syrrx Inc - Company Profile and News - Bloomberg Markets
Syrrx, Inc. manufactures medical products. The Company offers production, development, and commercialization of therapeutics drugs for the treatment of metabolic diseases, cancer, and …See details»
Syrrx, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Syrrx, Inc. with its drug pipeline, therapeutic area, technology platform, 5 news, and 22 literature.See details»
Syrrx - CoBee Company Profile & Funding Rounds
Syrrx Inc focuses on drug targets that have been validated in human clinical trials and directs its efforts toward therapeutics to treat metabolic diseases, cancer, and inflammation. Syrrx …See details»
Syrrx, Inc.:Company Profile & Technical Research,Competitor …
Syrrx, Inc. is a company that provides Clinical trial, Content management, Drug and more. Syrrx, Inc. is headquartered in United States California. Syrrx, Inc. was founded in 1999. Syrrx, Inc. …See details»
Syrrx, Inc. Company Profile | Jupiter, FL - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Syrrx, Inc. of Jupiter, FL. Get the latest business insights from Dun & Bradstreet.See details»
Syrrx - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Syrrx . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. Number of Board Member and …See details»
Syrrx Inc. - Scrip
In less than a year, Syrrx Inc. has raised $80 million of initial funding to build a business in structural proteomics--the process of generating protein structures from genetic information. …See details»
Syrrx Inc. - nsti.org
Syrrx Inc. 10410 Science Center Dr San Diego, California United States 858-622-8528 www.syrrx.com. Nanotechnology Company Directory . To add your company, or to update any …See details»
Syrrx - Company Profile & Staff Directory - ContactOut
Syrrx is a Biotechnology company located in San Diego, California with 2 employees. Access Syrrx's email format and Syrrx staff directory for direct contact details of 2 employees. ... Syrrx …See details»
Syrrx, Inc. (Syrrx, Inc.) - 药物管线_专利_临床试验_投融营收
在Syrrx工作期间，Nathaniel David也被《麻省理工学院技术评论》评为全球35岁以下最佳创新者之一。 在此之后，Nathaniel David先后创立了Achaogen（NASDAQ：AKAO）、Kythera …See details»
SYRRX AND MOLSOFT FORM STRATEGIC ALLIANCE
SAN DIEGO, CA October 31, 2000 Syrrx, Inc., a pioneer in the field of structural proteomics, and Molsoft, LLC, a leading developer of breakthrough technologies in computational biology, have …See details»
Takeda to buy Syrrx of USA - Pharmaceutical industry news | The ...
Feb 14, 2005 Japanese drug major Takeda has said it will take over the California, USA-based biotechnology company Syrrx for around $270.0 million. The acquisition will give Takeda, …See details»
Syrrx - Updates, News, Events, Signals & Triggers - Crunchbase
Syrrx, Inc. is a drug discovery company committed to redefining the way medicines are discovered.See details»
Startup Syrrx in Takeda R&D Center’s Lineage
May 14, 2019 Drug firm Takeda has moved over 250 San Diego-based employees into a new R&D center, adding to the company’s existing research centers in Boston and Kanagawa, …See details»
Syrrx, Novartis form strategic alliance - drugdiscoveryonline.com
Jan 8, 2001 For more information: Syrrx Inc., 10450 Science Center Dr., Suite 100, San Diego, CA 92121. Tel: 858-622-8528. With contributions from Jim Pomager Assistant Editor, Drug …See details»